ADAR1 Capital Management, LLC - 15 Oct 2025 SCHEDULE 13D/A Report for Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS)

Filing Manager
ADAR1 Capital Management, LLC
Reporting Manager
ADAR1 Capital Management, LLC
Security
Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
KROS
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13D/A
Filing time
15 Oct 2025, 06:50:13 UTC
Date of event
15 Oct 2025
Previous filing
21 Aug 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ADAR1 Capital Management, LLC 0% 0 0 0 /s/ Daniel Schneeberger Daniel Schneeberger, Manager 0001940272
ADAR1 Capital Management GP, LLC 0% 0 0 0 /s/ Daniel Schneeberger Daniel Schneeberger, Manager 0001940267
Daniel Schneeberger 0% 0 0 0 /s/ Daniel Schneeberger Daniel Schneeberger 0001861120